Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-19 Purchase | 2024-12-19 9:51 pm | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer | 12,000 | $2.55 | $30,600 | 222,236 (Direct) | View |
| 2022-06-27 Purchase | 2022-06-28 4:05 pm | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer | 2,500 | $3.8 | $9,500 | 210,236 (Direct) | View |
| 2021-11-19 Purchase | 2021-11-19 5:27 pm | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW CEO | 2,000 | $7.43 | $14,860 | 7,736 (Direct) | View |
| 2021-11-16 Purchase | 2021-11-18 4:24 pm | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW CEO | 2,000 | $7.87 | $15,740 | 5,736 (Direct) | View |
| 2021-05-18 Purchase | 2021-05-19 8:20 pm | Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW Chief Executive Officer | 3,000 | $5.47 | $16,410 | 3,736 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-18 Option Award | 2024-12-20 8:33 pm | N/A 2034-12-18 | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 5:05 pm | N/A 2033-12-05 | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 6:27 pm | N/A 2031-11-30 | enVVeno Medical Corp | NVNO | BERMAN ROBERT ANDREW Chief Executive Officer | 549,781 | $0 | 557,517 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 9:56 pm | N/A 2031-02-18 | Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW Chief Executive Officer | 838,000 | $0 | 838,000 (Direct) | View |
| 2020-07-18 Other | 2020-07-21 9:55 pm | 2018-04-26 2028-04-26 | Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW CEO | 1,080,207 | $0 | 1,080,207 (Direct) | View |
| 2020-07-18 Option Award | 2020-07-21 9:55 pm | N/A 2030-07-18 | Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW CEO | 1,080,207 | $0 | 1,080,207 (Direct) | View |
| 2020-07-18 Option Award | 2020-07-21 9:55 pm | N/A 2030-07-18 | Hancock Jaffe Laboratories Inc. | HJLI | BERMAN ROBERT ANDREW CEO | 1,000,000 | $0 | 1,000,000 (Direct) | View |